PIEZO1 and neoplasm: Pharmacologic inhibition of Piezo1 (e.g., with GsMTx4) can partly restore T-cell infiltration and boost effector function, highlighting the bidirectional regulatory role of Piezo1 in T-cell–tumor cell crosstalk.